- IBDEI3IZ ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,2430,0)
- ;;=EDUCATION/TRAINING GRP/IND^3^217
- ;;^UTILITY(U,$J,358.4,2431,0)
- ;;=SUPPLIES^10^217
- ;;^UTILITY(U,$J,358.4,2432,0)
- ;;=ESTABLISHED PT-OUTPT^1^218
- ;;^UTILITY(U,$J,358.4,2433,0)
- ;;=INPATIENT CARE^2^218
- ;;^UTILITY(U,$J,358.4,2434,0)
- ;;=COMMON PULMONARY DX^1^219
- ;;^UTILITY(U,$J,358.4,2435,0)
- ;;=SLEEP DISORDERS^20^219
- ;;^UTILITY(U,$J,358.4,2436,0)
- ;;=OBSTRUCTIVE SLEEP APNEA^13^219
- ;;^UTILITY(U,$J,358.4,2437,0)
- ;;=OTHER^26^219
- ;;^UTILITY(U,$J,358.4,2438,0)
- ;;=CANCER^2^219
- ;;^UTILITY(U,$J,358.4,2439,0)
- ;;=CARDIAC^3^219
- ;;^UTILITY(U,$J,358.4,2440,0)
- ;;=ENDOCRINE^4^219
- ;;^UTILITY(U,$J,358.4,2441,0)
- ;;=ENT^5^219
- ;;^UTILITY(U,$J,358.4,2442,0)
- ;;=GASTROINTESTINAL^5^219
- ;;^UTILITY(U,$J,358.4,2443,0)
- ;;=GENITOURINARY/RENAL^6^219
- ;;^UTILITY(U,$J,358.4,2444,0)
- ;;=HEMATOLOGIC/LYMPHATIC^7^219
- ;;^UTILITY(U,$J,358.4,2445,0)
- ;;=HEPATIC/BILIARY^8^219
- ;;^UTILITY(U,$J,358.4,2446,0)
- ;;=INFECTIOUS DISEASE^9^219
- ;;^UTILITY(U,$J,358.4,2447,0)
- ;;=INTERSTITIAL LUNG DISEASE^10^219
- ;;^UTILITY(U,$J,358.4,2448,0)
- ;;=MUSCULOSKELETAL^11^219
- ;;^UTILITY(U,$J,358.4,2449,0)
- ;;=SUTURES^23^219
- ;;^UTILITY(U,$J,358.4,2450,0)
- ;;=RADIATION^19^219
- ;;^UTILITY(U,$J,358.4,2451,0)
- ;;=OCCUPATIONAL^15^219
- ;;^UTILITY(U,$J,358.4,2452,0)
- ;;=PAIN^16^219
- ;;^UTILITY(U,$J,358.4,2453,0)
- ;;=PLEURAL DISEASE^17^219
- ;;^UTILITY(U,$J,358.4,2454,0)
- ;;=PSYCHIATRIC/BEHAVIORAL^18^219
- ;;^UTILITY(U,$J,358.4,2455,0)
- ;;=SKIN^22^219
- ;;^UTILITY(U,$J,358.4,2456,0)
- ;;=NEUROLOGIC^12^219
- ;;^UTILITY(U,$J,358.4,2457,0)
- ;;=OBSTRUCTIVE DISEASE^14^219
- ;;^UTILITY(U,$J,358.4,2458,0)
- ;;=VASCULAR^24^219
- ;;^UTILITY(U,$J,358.4,2459,0)
- ;;=SYMPTOMS^21^219
- ;;^UTILITY(U,$J,358.4,2460,0)
- ;;=ASPIRATION/INJECTION^1^220
- ;;^UTILITY(U,$J,358.4,2461,0)
- ;;=INJECTION MEDICATIONS^2^220
- ;;^UTILITY(U,$J,358.4,2462,0)
- ;;=ULTRASOUND^3^220
- ;;^UTILITY(U,$J,358.4,2463,0)
- ;;=NEW PATIENT^2^221
- ;;^UTILITY(U,$J,358.4,2464,0)
- ;;=ESTABLISHED PATIENT^1^221
- ;;^UTILITY(U,$J,358.4,2465,0)
- ;;=CONSULTATIONS^3^221
- ;;^UTILITY(U,$J,358.4,2466,0)
- ;;=COMMON DIAGNOSES^1^222
- ;;^UTILITY(U,$J,358.4,2467,0)
- ;;=CRYSTAL ARTHROPATHIES^2^222
- ;;^UTILITY(U,$J,358.4,2468,0)
- ;;=JOINT DISORDERS^5^222
- ;;^UTILITY(U,$J,358.4,2469,0)
- ;;=MISCELLANEOUS^6^222
- ;;^UTILITY(U,$J,358.4,2470,0)
- ;;=NERVOUS SYSTEM^7^222
- ;;^UTILITY(U,$J,358.4,2471,0)
- ;;=OSTEOARTHRITIS^8^222
- ;;^UTILITY(U,$J,358.4,2472,0)
- ;;=OSTEOMYELITIS^9^222
- ;;^UTILITY(U,$J,358.4,2473,0)
- ;;=OSTEOPOROSIS^10^222
- ;;^UTILITY(U,$J,358.4,2474,0)
- ;;=PYOGENIC ARTHRITIS^11^222
- ;;^UTILITY(U,$J,358.4,2475,0)
- ;;=SPINE DISORDERS^12^222
- ;;^UTILITY(U,$J,358.4,2476,0)
- ;;=TENDINITIS & BURSITIS^13^222
- ;;^UTILITY(U,$J,358.4,2477,0)
- ;;=VASCULAR DISORDERS^16^222
- ;;^UTILITY(U,$J,358.4,2478,0)
- ;;=VASCULITIS CONDITIONS^15^222
- ;;^UTILITY(U,$J,358.4,2479,0)
- ;;=INFECTIONS^3^222
- ;;^UTILITY(U,$J,358.4,2480,0)
- ;;=INT DERANGEMENT OF KNEE^4^222
- ;;^UTILITY(U,$J,358.4,2481,0)
- ;;=OTHER INFLAMMATORY^10.5^222
- ;;^UTILITY(U,$J,358.4,2482,0)
- ;;=VACCINATIONS^13^223
- ;;^UTILITY(U,$J,358.4,2483,0)
- ;;=INJECTION^7^223
- ;;^UTILITY(U,$J,358.4,2484,0)
- ;;=EDUCATION/TRAINING^3^223
- ;;^UTILITY(U,$J,358.4,2485,0)
- ;;=COUNSELING^2^223
- ;;^UTILITY(U,$J,358.4,2486,0)
- ;;=EVALUATIONS^4^223
- ;;^UTILITY(U,$J,358.4,2487,0)
- ;;=SPINAL INJECTION CODES^9^223
- ;;^UTILITY(U,$J,358.4,2488,0)
- ;;=SUPPLIES^10^223
- ;;^UTILITY(U,$J,358.4,2489,0)
- ;;=TREATMENT PROCEDURES^11^223
- ;;^UTILITY(U,$J,358.4,2490,0)
- ;;=TRIGGER POINT INJECTIONS^12^223
- ;;^UTILITY(U,$J,358.4,2491,0)
- ;;=HOME VISIT-ESTABLISHED PT^5^223
- ;;^UTILITY(U,$J,358.4,2492,0)
- ;;=HOME VISIT-NEW PT^6^223
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3IZ 3991 printed Mar 13, 2025@21:54:44 Page 2
- IBDEI3IZ ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,2430,0)
- +2 ;;=EDUCATION/TRAINING GRP/IND^3^217
- +3 ;;^UTILITY(U,$J,358.4,2431,0)
- +4 ;;=SUPPLIES^10^217
- +5 ;;^UTILITY(U,$J,358.4,2432,0)
- +6 ;;=ESTABLISHED PT-OUTPT^1^218
- +7 ;;^UTILITY(U,$J,358.4,2433,0)
- +8 ;;=INPATIENT CARE^2^218
- +9 ;;^UTILITY(U,$J,358.4,2434,0)
- +10 ;;=COMMON PULMONARY DX^1^219
- +11 ;;^UTILITY(U,$J,358.4,2435,0)
- +12 ;;=SLEEP DISORDERS^20^219
- +13 ;;^UTILITY(U,$J,358.4,2436,0)
- +14 ;;=OBSTRUCTIVE SLEEP APNEA^13^219
- +15 ;;^UTILITY(U,$J,358.4,2437,0)
- +16 ;;=OTHER^26^219
- +17 ;;^UTILITY(U,$J,358.4,2438,0)
- +18 ;;=CANCER^2^219
- +19 ;;^UTILITY(U,$J,358.4,2439,0)
- +20 ;;=CARDIAC^3^219
- +21 ;;^UTILITY(U,$J,358.4,2440,0)
- +22 ;;=ENDOCRINE^4^219
- +23 ;;^UTILITY(U,$J,358.4,2441,0)
- +24 ;;=ENT^5^219
- +25 ;;^UTILITY(U,$J,358.4,2442,0)
- +26 ;;=GASTROINTESTINAL^5^219
- +27 ;;^UTILITY(U,$J,358.4,2443,0)
- +28 ;;=GENITOURINARY/RENAL^6^219
- +29 ;;^UTILITY(U,$J,358.4,2444,0)
- +30 ;;=HEMATOLOGIC/LYMPHATIC^7^219
- +31 ;;^UTILITY(U,$J,358.4,2445,0)
- +32 ;;=HEPATIC/BILIARY^8^219
- +33 ;;^UTILITY(U,$J,358.4,2446,0)
- +34 ;;=INFECTIOUS DISEASE^9^219
- +35 ;;^UTILITY(U,$J,358.4,2447,0)
- +36 ;;=INTERSTITIAL LUNG DISEASE^10^219
- +37 ;;^UTILITY(U,$J,358.4,2448,0)
- +38 ;;=MUSCULOSKELETAL^11^219
- +39 ;;^UTILITY(U,$J,358.4,2449,0)
- +40 ;;=SUTURES^23^219
- +41 ;;^UTILITY(U,$J,358.4,2450,0)
- +42 ;;=RADIATION^19^219
- +43 ;;^UTILITY(U,$J,358.4,2451,0)
- +44 ;;=OCCUPATIONAL^15^219
- +45 ;;^UTILITY(U,$J,358.4,2452,0)
- +46 ;;=PAIN^16^219
- +47 ;;^UTILITY(U,$J,358.4,2453,0)
- +48 ;;=PLEURAL DISEASE^17^219
- +49 ;;^UTILITY(U,$J,358.4,2454,0)
- +50 ;;=PSYCHIATRIC/BEHAVIORAL^18^219
- +51 ;;^UTILITY(U,$J,358.4,2455,0)
- +52 ;;=SKIN^22^219
- +53 ;;^UTILITY(U,$J,358.4,2456,0)
- +54 ;;=NEUROLOGIC^12^219
- +55 ;;^UTILITY(U,$J,358.4,2457,0)
- +56 ;;=OBSTRUCTIVE DISEASE^14^219
- +57 ;;^UTILITY(U,$J,358.4,2458,0)
- +58 ;;=VASCULAR^24^219
- +59 ;;^UTILITY(U,$J,358.4,2459,0)
- +60 ;;=SYMPTOMS^21^219
- +61 ;;^UTILITY(U,$J,358.4,2460,0)
- +62 ;;=ASPIRATION/INJECTION^1^220
- +63 ;;^UTILITY(U,$J,358.4,2461,0)
- +64 ;;=INJECTION MEDICATIONS^2^220
- +65 ;;^UTILITY(U,$J,358.4,2462,0)
- +66 ;;=ULTRASOUND^3^220
- +67 ;;^UTILITY(U,$J,358.4,2463,0)
- +68 ;;=NEW PATIENT^2^221
- +69 ;;^UTILITY(U,$J,358.4,2464,0)
- +70 ;;=ESTABLISHED PATIENT^1^221
- +71 ;;^UTILITY(U,$J,358.4,2465,0)
- +72 ;;=CONSULTATIONS^3^221
- +73 ;;^UTILITY(U,$J,358.4,2466,0)
- +74 ;;=COMMON DIAGNOSES^1^222
- +75 ;;^UTILITY(U,$J,358.4,2467,0)
- +76 ;;=CRYSTAL ARTHROPATHIES^2^222
- +77 ;;^UTILITY(U,$J,358.4,2468,0)
- +78 ;;=JOINT DISORDERS^5^222
- +79 ;;^UTILITY(U,$J,358.4,2469,0)
- +80 ;;=MISCELLANEOUS^6^222
- +81 ;;^UTILITY(U,$J,358.4,2470,0)
- +82 ;;=NERVOUS SYSTEM^7^222
- +83 ;;^UTILITY(U,$J,358.4,2471,0)
- +84 ;;=OSTEOARTHRITIS^8^222
- +85 ;;^UTILITY(U,$J,358.4,2472,0)
- +86 ;;=OSTEOMYELITIS^9^222
- +87 ;;^UTILITY(U,$J,358.4,2473,0)
- +88 ;;=OSTEOPOROSIS^10^222
- +89 ;;^UTILITY(U,$J,358.4,2474,0)
- +90 ;;=PYOGENIC ARTHRITIS^11^222
- +91 ;;^UTILITY(U,$J,358.4,2475,0)
- +92 ;;=SPINE DISORDERS^12^222
- +93 ;;^UTILITY(U,$J,358.4,2476,0)
- +94 ;;=TENDINITIS & BURSITIS^13^222
- +95 ;;^UTILITY(U,$J,358.4,2477,0)
- +96 ;;=VASCULAR DISORDERS^16^222
- +97 ;;^UTILITY(U,$J,358.4,2478,0)
- +98 ;;=VASCULITIS CONDITIONS^15^222
- +99 ;;^UTILITY(U,$J,358.4,2479,0)
- +100 ;;=INFECTIONS^3^222
- +101 ;;^UTILITY(U,$J,358.4,2480,0)
- +102 ;;=INT DERANGEMENT OF KNEE^4^222
- +103 ;;^UTILITY(U,$J,358.4,2481,0)
- +104 ;;=OTHER INFLAMMATORY^10.5^222
- +105 ;;^UTILITY(U,$J,358.4,2482,0)
- +106 ;;=VACCINATIONS^13^223
- +107 ;;^UTILITY(U,$J,358.4,2483,0)
- +108 ;;=INJECTION^7^223
- +109 ;;^UTILITY(U,$J,358.4,2484,0)
- +110 ;;=EDUCATION/TRAINING^3^223
- +111 ;;^UTILITY(U,$J,358.4,2485,0)
- +112 ;;=COUNSELING^2^223
- +113 ;;^UTILITY(U,$J,358.4,2486,0)
- +114 ;;=EVALUATIONS^4^223
- +115 ;;^UTILITY(U,$J,358.4,2487,0)
- +116 ;;=SPINAL INJECTION CODES^9^223
- +117 ;;^UTILITY(U,$J,358.4,2488,0)
- +118 ;;=SUPPLIES^10^223
- +119 ;;^UTILITY(U,$J,358.4,2489,0)
- +120 ;;=TREATMENT PROCEDURES^11^223
- +121 ;;^UTILITY(U,$J,358.4,2490,0)
- +122 ;;=TRIGGER POINT INJECTIONS^12^223
- +123 ;;^UTILITY(U,$J,358.4,2491,0)
- +124 ;;=HOME VISIT-ESTABLISHED PT^5^223
- +125 ;;^UTILITY(U,$J,358.4,2492,0)
- +126 ;;=HOME VISIT-NEW PT^6^223
